CONMED Corp — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2021-03-01

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	M	3221	$39.87	Acquired	16929	Direct
2021-03-01	Common Stock	S	3221	$123.2596	Disposed	13708	Direct
2021-03-01	Common Stock	M	624	$41.93	Acquired	14332	Direct
2021-03-01	Common Stock	S	624	$123.2752	Disposed	13708	Direct
2021-03-01	Common Stock	M	3500	$41.93	Acquired	17208	Direct
2021-03-01	Common Stock	F	2345	$123.20	Disposed	14863	Direct
2021-03-02	Common Stock	M	2199	$39.87	Acquired	17062	Direct
2021-03-02	Common Stock	S	2199	$121.8437	Disposed	14863	Direct
2021-03-02	Common Stock	M	1000	$41.93	Acquired	15863	Direct
2021-03-02	Common Stock	S	1000	$121.9194	Disposed	14863	Direct
2021-03-02	Common Stock	G	800	—	Disposed	14063	Direct
2021-03-02	Common Stock	G	150	—	Disposed	13913	Direct
2021-03-02	Common Stock	G	150	—	Disposed	13763	Direct
2021-03-02	Common Stock	G	150	—	Acquired	450	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Options To Purchase Common Stock	$39.87	M	3221	Disposed	2026-03-01	Common Stock (3221)	Direct
2021-03-01	Options To Purchase Common Stock	$41.93	M	624	Disposed	2027-03-01	Common Stock (624)	Direct
2021-03-01	Options To Purchase Common Stock	$41.93	M	3500	Disposed	2027-03-01	Common Stock (3500)	Direct
2021-03-01	Options To Purchase Common Stock	$122.55	A	21250	Acquired	2031-03-01	Common Stock (21250)	Direct
2021-03-02	Options To Purchase Common Stock	$39.87	M	2199	Disposed	2026-03-01	Common Stock (2199)	Direct
2021-03-02	Options To Purchase Common Stock	$41.93	M	1000	Disposed	2027-03-01	Common Stock (1000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.49. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.405. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.22. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F5: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F6: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period